REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Disessifarma Cia.Ltda (Ecuador)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Disessifarma Cia.Ltda Profile Updated: May 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Disessifarma Cia.Ltda is an enterprise based in Ecuador. Its main office is in Guayaquil. The company operates in the Pharmaceutical and Medicine Manufacturing industry. It was incorporated on March 15, 2018. 5 (2023) employees currently work for Disessifarma Cia.Ltda. There was a net sales revenue increase of 129.9% reported in Disessifarma Cia.Ltda’s latest financial highlights for 2023. Over the same period, its total assets grew by 88.13%. In 2023, Disessifarma Cia.Ltda’s net profit margin decreased by 4.52%.

Headquarters
Quisquis Sol 13b
Guayaquil; Guayas;

Contact Details: Purchase the Disessifarma Cia.Ltda report to view the information.

Basic Information
Total Employees:
Purchase the Disessifarma Cia.Ltda report to view the information.
Outstanding Shares:
Purchase the Disessifarma Cia.Ltda report to view the information.
Registered Capital:
Purchase the Disessifarma Cia.Ltda report to view the information.
Incorporation Date:
March 15, 2018
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
40%
Purchase this report to view the information.
30%
Purchase this report to view the information.
30%
Company Performance
Financial values in the chart are available after Disessifarma Cia.Ltda report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
129.9%▲
Total operating revenue
130.43%▲
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
-41.43%▼
Total assets
88.13%▲
Total equity
31.38%▲
Operating Profit Margin (ROS)
N/A
Net Profit Margin
-4.52%▼
Return on Equity (ROE)
7.85%▲
Quick Ratio
-1.35%▼
Cash Ratio
0.17%▲

Similar companies

Laboratorios Siegfried S.A.
 
Roche Ecuador S.A.
Bayer S.A.
 
Novartis Ecuador S.A.
Laboratorios Industriales Farmaceuticos Ecuatorianos Life
 
Nefrocontrol S.A.
Pharmapri CIA Ltda
 
Industria Farmaceutica Reyes & Verduga Revloh Cia.Ltda
Biomontecuador S.A.
 
Innovapharm S.A.S.
Farmanacion S.A.
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo